Deborah R. McCarty

961 total citations
12 papers, 815 citations indexed

About

Deborah R. McCarty is a scholar working on Cellular and Molecular Neuroscience, Physiology and Organic Chemistry. According to data from OpenAlex, Deborah R. McCarty has authored 12 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 4 papers in Physiology and 3 papers in Organic Chemistry. Recurrent topics in Deborah R. McCarty's work include Neuroscience and Neuropharmacology Research (4 papers), Neuropeptides and Animal Physiology (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). Deborah R. McCarty is often cited by papers focused on Neuroscience and Neuropharmacology Research (4 papers), Neuropeptides and Animal Physiology (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). Deborah R. McCarty collaborates with scholars based in United States, United Kingdom and Canada. Deborah R. McCarty's co-authors include B M Baron, Matthew D. Linnik, Carrie G. Markgraf, Nelson L. Velayo, Michael P. Johnson, Jack R. Koehl, Paula A. Chmielewski, Jack Elands, Barry W. Siegel and John H. Kehne and has published in prestigious journals such as Stroke, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Deborah R. McCarty

12 papers receiving 797 citations

Peers

Deborah R. McCarty
Erik I. Charych United States
E. A. Singer Austria
Karin Schmuck Switzerland
Valentina Ghisi United States
Erik I. Charych United States
Deborah R. McCarty
Citations per year, relative to Deborah R. McCarty Deborah R. McCarty (= 1×) peers Erik I. Charych

Countries citing papers authored by Deborah R. McCarty

Since Specialization
Citations

This map shows the geographic impact of Deborah R. McCarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah R. McCarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah R. McCarty more than expected).

Fields of papers citing papers by Deborah R. McCarty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah R. McCarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah R. McCarty. The network helps show where Deborah R. McCarty may publish in the future.

Co-authorship network of co-authors of Deborah R. McCarty

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah R. McCarty. A scholar is included among the top collaborators of Deborah R. McCarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah R. McCarty. Deborah R. McCarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Benschop, Robert J., Emily C. Collins, Ryan J. Darling, et al.. (2014). Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain. Osteoarthritis and Cartilage. 22(4). 578–585. 100 indexed citations
2.
Yan, Liang, Kirk W. Johnson, Emily C. Rothstein, et al.. (2011). Discovery of potent, cyclic calcitonin gene‐related peptide receptor antagonists. Journal of Peptide Science. 17(5). 383–386. 11 indexed citations
3.
Lao, Christopher D., Patricia M. Backoff, Lawrence I. Shotland, et al.. (2004). Irreversible Ototoxicity Associated with Difluoromethylornithine. Cancer Epidemiology Biomarkers & Prevention. 13(7). 1250–1252. 15 indexed citations
4.
O’Neill, Michael J., Caroline Hicks, Mark Ward, et al.. (2001). LY393615, a novel neuronal Ca2+ and Na+ channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia. Brain Research. 888(1). 138–149. 12 indexed citations
5.
O’Neill, Michael J., Tracey K. Murray, Deborah R. McCarty, et al.. (2000). ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia. Brain Research. 871(2). 234–244. 40 indexed citations
6.
Markgraf, Carrie G., Nelson L. Velayo, Michael P. Johnson, et al.. (1998). Six-Hour Window of Opportunity for Calpain Inhibition in Focal Cerebral Ischemia in Rats. Stroke. 29(1). 152–158. 203 indexed citations
7.
Petty, Margaret A., Jack Elands, Michael P. Johnson, et al.. (1997). The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine. European Journal of Pharmacology. 336(2-3). 127–136. 8 indexed citations
8.
Kehne, John H., B M Baron, A A Carr, et al.. (1996). Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile.. Journal of Pharmacology and Experimental Therapeutics. 277(2). 968–981. 318 indexed citations
9.
Peet, Norton P., et al.. (1993). Xanthines with C8 chiral substituents as potent and selective adenosine A1 antagonists. Journal of Medicinal Chemistry. 36(25). 4015–4020. 9 indexed citations
10.
Sprouse, Jeffrey, Deborah R. McCarty, & Mark W. Dudley. (1993). Apparent regional differences in 5-HT1A binding may reflect [3H]8-OH-DPAT labeling of serotonin uptake sites. Brain Research. 617(1). 159–162. 15 indexed citations
11.
Baron, B M, Mark W. Dudley, Deborah R. McCarty, et al.. (1989). Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.. Journal of Pharmacology and Experimental Therapeutics. 250(1). 162–169. 82 indexed citations
12.
Dudley, Mark W., et al.. (1988). A low dose of xylamine produces sustained and selective decreases in rat brain norepinephrine without evidence of neuronal degeneration.. Journal of Pharmacology and Experimental Therapeutics. 247(1). 174–179. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026